Abstract
ObjectiveTo investigate whether the occurrence of nocturnal asymptomatic hypoglycemia may be predicted based on fasting glucose levels and post-breakfast glucose fluctuations.Patients and MethodsThe study subjects comprised type 1 diabetic patients who underwent CGM assessments and received basal-bolus insulin therapy with long-acting insulin. The subjects were evaluated for I) fasting glucose levels and II) the range of post-breakfast glucose elevation (from fasting glucose levels to postprandial 1- and 2-hour glucose levels). The patients were divided into those with asymptomatic hypoglycemia during nighttime and those without for comparison. Optimal cut-off values were also determined for relevant parameters that could predict nighttime hypoglycemia by using ROC analysis.Results64 patients (mean HbA1c 8.7 ± 1.8%) were available for analysis. Nocturnal asymptomatic hypoglycemia occurred in 23 patients (35.9%). Fasting glucose levels (I) were significantly lower in those with hypoglycemia than those without (118 ± 35 mg/dL vs. 179 ± 65 mg/dL; P < 0.001). The range of post-breakfast glucose elevation (II) was significantly greater in those with hypoglycemia than in those without (postprandial 1-h, P = 0.003; postprandial 2-h, P = 0.005). The cut-off values determined for relevant factors were as follows: (I) fasting glucose level < 135 mg/dL (sensitivity 0.73/specificity 0.83/AUC 0.79, P < 0.001); and (II) 1-h postprandial elevation > 54 mg/dL (0.65/0.61/0.71, P = 0.006), 2-h postprandial elevation > 78 mg/dL (0.65/0.73/0.71, P = 0.005).ConclusionsNocturnal asymptomatic hypoglycemia was associated with increases in post-breakfast glucose levels in type 1 diabetes. Study findings also suggest that fasting glucose levels and the range of post-breakfast glucose elevation could help predict the occurrence of nocturnal asymptomatic hypoglycemia.
Highlights
The goal of diabetes treatment is to prevent the onset of diabetic complications and to ensure quality of life (QOL) and longevity comparable to those in healthy individuals by controlling glucose and metabolism
Nocturnal asymptomatic hypoglycemia occurred in 23 patients (35.9%)
Nocturnal asymptomatic hypoglycemia was associated with increases in post-breakfast glucose levels in type 1 diabetes
Summary
The goal of diabetes treatment is to prevent the onset of diabetic complications and to ensure quality of life (QOL) and longevity comparable to those in healthy individuals by controlling glucose and metabolism. Large-scale clinical studies found that lowering HbA1c levels does not necessarily result in improved life prognosis [1,2,3]. Glucose control aimed at HbA1c reductions may be associated with increased risk of hypoglycemia [4]. A sub-analysis of the ADVANCE study reported that serious hypoglycemia is a determinant of prognosis in cardiovascular and overall mortality [5]. Hypoglycemia is reported to induce arrhythmia [6], especially in nocturnal hypoglycemia leading to increased sympathetic nerve activity, followed by over-compensatory vagal activity, causing life-threatening brachycardia [7]. It is suggested that nocturnal hypoglycemia may be associated with the so-called “dead in bed” syndrome or sudden death [8,9,10,11]
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have